Načítá se...
Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
BACKGROUND: The prevention of relapse is a major issue in the management of Crohn's disease. Corticosteroids, the mainstay of treatment of acute exacerbations, are not effective for maintenance of remission and its chronic use is limited by numerous adverse events. Randomised controlled trials...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2016
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457838/ https://ncbi.nlm.nih.gov/pubmed/27681657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003715.pub3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|